104 Recurrent Group B Streptococcus Infections Among Non-Pregnant Adults, United States, 1996-2011

Sunday, June 19, 2016: 3:00 PM-3:30 PM
Exhibit Hall Section 1, Dena'ina Convention Center
Corinne Holtzman , Minnesota Department of Health, St. Paul, MN
Joan Baumbach , New Mexico Department of Health, Santa Fe, NM
Monica M. Farley , Atlanta VA Medical Center, Decatur, GA
Lee H. Harrison , Maryland Department of Health and Mental Hygiene, Baltimore, MD
Lisa Miller , Colorado Department of Public Health and Environment, Denver, CO
Susan Petit , Connecticut Department of Public Health, Hartford, CT
Arthur Reingold , University of California, Berkeley, Berkeley, CA
William Schaffner , Vanderbilt University School of Medicine, Nashville, TN
Ann Thomas , Oregon Department of Health, Portland, OR
Shelly Zansky , New York State Department of Health, Albany, NY
Richard N Danila , Minnesota Department of Health, St. Paul, MN

BACKGROUND:  Most (>80%) invasive GBS (iGBS) disease occurs in non-pregnant adults. Some individuals have recurrent iGBS.  We examined and compared clinical and epidemiological characteristics of recurrent vs. non-recurrent iGBS among U.S. adults. 

METHODS:  CDC’s Active Bacterial Core Surveillance, is a network of 10 U.S. sites; of these, 9 conduct population-based surveillance for iGBS among adults (isolated from a normally sterile site).  Recurrent cases were defined as occurring >30 days and ≤2 years after initial GBS culture. Medical records were reviewed for clinical information.  This analysis included cases reported from 1996-2011 who survived initial infection. The Cochran-Armitage test for trend was used to assess changes in proportions by 1-year intervals.

RESULTS:   Analysis of 23,140 iGBS cases in non-pregnant adults who survived initial infection demonstrated that iGBS incidence increased from 4.8 to 8.6 cases/100,000 persons (x2 for trend: p < 0.001) during 1996-2011.  Among these cases, 763 (3.3%) had ≥1 recurrence: 46% ≤6 months and 88% ≤18 months.  Among recurrent cases, 89 had 3, 20 had 4-5, and 3 had >5 infections within 2 years. Recurrent GBS incidence increased from 0.17 to 0.28 cases/100,000 persons during 1996 to 2011 (x2for trend: p < 0.001). In 1997, 44% recurrent cases were <65 years; by 2011, 59% were aged <65 years at time of initial culture (trend: z= -2.5, 2-sided p = 0.01).  Obesity at initial infection was reported in 33% of recurrent iGBS cases versus 24% with non-recurrent disease (x2: p = 0.003). Additionally, the proportion of recurrent iGBS cases with obesity increased over time (38% in 2005 to 53% in 2011 trend: z= 2.7, 2-sided p < 0.001), but not the proportion with diabetes, heart disease, or immunosuppression. There were no differences in these co-morbidities in recurrent vs. non-recurrent iGBS. The most common syndromes among recurrent and non-recurrent cases were primary bacteremia, cellulitis, and osteomyelitis/septic arthritis.  Among recurrent cases, 38% (289/763) had a different presentation during their second infection.  The proportion of recurrent cases with osteomyelitis/septic arthritis as initial infection increased over time; 14% (1996) to 24% (2011) (trend: z= 2.3, 2-sided p = 0.02).

CONCLUSIONS:  Incidence of both primary and recurrent iGBS increased over 16 years.  Among recurrent cases, age decreased, prevalence of obesity and the frequency of bone/joint infections at the time of initial GBS infection increased.  Further investigation of risk factors for recurrence may help inform prevention measures.